A Trial of Etelcalcetide in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis

ClinicalTrials.gov ID: NCT03633708

Public ClinicalTrials.gov record NCT03633708. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 22, 2026, 2:06 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase 3, Randomized, Open-label, Controlled, Multiple Dose, Efficacy, Safety, Pharmacokinetic, and Pharmacodynamic Study of Etelcalcetide in Pediatric Subjects 28 Days to < 18 Years of Age With Secondary Hyperparathyroidism and Chronic Kidney Disease Receiving Maintenance Hemodialysis

Study identification

NCT ID: NCT03633708
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 3
Lead sponsor: Amgen; Industry
Enrollment: 56 participants

Conditions and interventions

Conditions

Interventions

Etelcalcetide Drug
Standard of Care Other

Drug · Other

Eligibility (public fields only)

Age range: 0 Years to 18 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Apr 28, 2019
Primary completion: Jan 30, 2029
Completion: Jan 30, 2029
Last update posted: Feb 26, 2026

2019 – 2029

United States locations

U.S. sites: 10
U.S. states: 9
U.S. cities: 10

Facility	City	State	ZIP	Site status
Childrens Hospital of Los Angeles	Los Angeles	California	90027	Recruiting
Childrens Hospital Colorado	Aurora	Colorado	80045	Terminated
Childrens Mercy Hospital	Kansas City	Missouri	64108	Recruiting
Mount Sinai Kidney Center - B1 Renal Treatment	New York	New York	10029	Completed
Cincinnati Childrens Hospital Medical Center	Cincinnati	Ohio	45229	Completed
Cleveland Clinic Foundation	Cleveland	Ohio	44195	Recruiting
The Childrens Hospital at Oklahoma University Medical Center	Oklahoma City	Oklahoma	73104	Completed
Childrens Hospital of Philadelphia	Philadelphia	Pennsylvania	19104	Recruiting
Childrens Medical Center Dallas	Dallas	Texas	75390	Terminated
Primary Childrens Hospital Outpatient Services	Salt Lake City	Utah	84113	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 33 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT03633708, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Feb 26, 2026 · Synced Jul 22, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03633708 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →